Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae54ff84e44df70336757a88d4be0e57 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate |
2011-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667f1e521df2ff89fd9602ec760e94f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4229aecba207666aef0a37811dc8887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8729c2e214d6ee0c66668ddc3996b37c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4a5a32bc6c492d16000c3df24f4f6f7 |
publicationDate |
2013-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EA-019020-B1 |
titleOfInvention |
Method of treating hemostasis disorders in the brains |
abstract |
The invention relates to the field of medicine and will find application in the complex treatment of brain contusions. The essence of the invention lies in the fact that freshly frozen plasma from 250 to 1000 ml / kg is administered daily to the patient for the first three days, then from the third day they switch to daily administration of perftoran at a dose of 2-5 ml / kg body weight and then clexane to a dose of 20-60 mg / kg for 7-35 days. |
priorityDate |
2011-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |